348 related articles for article (PubMed ID: 25333849)
1. Chromatin remodeler mutations in human cancers: epigenetic implications.
Skulte KA; Phan L; Clark SJ; Taberlay PC
Epigenomics; 2014; 6(4):397-414. PubMed ID: 25333849
[TBL] [Abstract][Full Text] [Related]
2. Long non-coding RNAs: the tentacles of chromatin remodeler complexes.
Neve B; Jonckheere N; Vincent A; Van Seuningen I
Cell Mol Life Sci; 2021 Feb; 78(4):1139-1161. PubMed ID: 33001247
[TBL] [Abstract][Full Text] [Related]
3. Epigenetics and cancer: altered chromatin remodeling via Snf5 loss leads to aberrant cell cycle regulation.
Sansam CG; Roberts CW
Cell Cycle; 2006 Mar; 5(6):621-4. PubMed ID: 16582616
[TBL] [Abstract][Full Text] [Related]
4. Differential Expression of SWI/SNF Chromatin Remodeler Subunits Brahma and Brahma-Related Gene During Drug-Induced Liver Injury and Regeneration in Mouse Model.
Sinha S; Verma S; Chaturvedi MM
DNA Cell Biol; 2016 Aug; 35(8):373-84. PubMed ID: 27097303
[TBL] [Abstract][Full Text] [Related]
5. SWI/SNF chromatin remodeling and human malignancies.
Masliah-Planchon J; Bièche I; Guinebretière JM; Bourdeaut F; Delattre O
Annu Rev Pathol; 2015; 10():145-71. PubMed ID: 25387058
[TBL] [Abstract][Full Text] [Related]
6. Inactivating mutations in SWI/SNF chromatin remodeling genes in human cancer.
Oike T; Ogiwara H; Nakano T; Yokota J; Kohno T
Jpn J Clin Oncol; 2013 Sep; 43(9):849-55. PubMed ID: 23904343
[TBL] [Abstract][Full Text] [Related]
7. Multiple interactions of the oncoprotein transcription factor MYC with the SWI/SNF chromatin remodeler.
Woodley CM; Romer AS; Wang J; Guarnaccia AD; Elion DL; Maxwell JN; Guerrazzi K; McCann TS; Popay TM; Matlock BK; Flaherty DK; Lorey SL; Liu Q; Tansey WP; Weissmiller AM
Oncogene; 2021 May; 40(20):3593-3609. PubMed ID: 33931740
[TBL] [Abstract][Full Text] [Related]
8. [Chromatin remodeling defects and cancer: the SWI/SNF example].
Bourdeaut F; Bièche I
Bull Cancer; 2012 Dec; 99(12):1133-40. PubMed ID: 23222069
[TBL] [Abstract][Full Text] [Related]
9. SWI/SNF complexes and cancers.
Wang L; Tang J
Gene; 2023 Jun; 870():147420. PubMed ID: 37031881
[TBL] [Abstract][Full Text] [Related]
10. Targeting of BRM Sensitizes
Zernickel E; Sak A; Riaz A; Klein D; Groneberg M; Stuschke M
Mol Cancer Ther; 2019 Mar; 18(3):656-666. PubMed ID: 30478150
[TBL] [Abstract][Full Text] [Related]
11. Intrinsic Disorder of the BAF Complex: Roles in Chromatin Remodeling and Disease Development.
El Hadidy N; Uversky VN
Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31652801
[TBL] [Abstract][Full Text] [Related]
12. The SWI/SNF BAF-A complex is essential for neural crest development.
Chandler RL; Magnuson T
Dev Biol; 2016 Mar; 411(1):15-24. PubMed ID: 26806701
[TBL] [Abstract][Full Text] [Related]
13. The role of the SWI/SNF chromatin remodeling complex in pancreatic ductal adenocarcinoma.
Tsuda M; Fukuda A; Kawai M; Araki O; Seno H
Cancer Sci; 2021 Feb; 112(2):490-497. PubMed ID: 33301642
[TBL] [Abstract][Full Text] [Related]
14. Diverse functions of ATP-dependent chromatin remodeling complexes in development and cancer.
Wu JI
Acta Biochim Biophys Sin (Shanghai); 2012 Jan; 44(1):54-69. PubMed ID: 22194014
[TBL] [Abstract][Full Text] [Related]
15. Unwinding chromatin for development and growth: a few genes at a time.
Kwon CS; Wagner D
Trends Genet; 2007 Aug; 23(8):403-12. PubMed ID: 17566593
[TBL] [Abstract][Full Text] [Related]
16. Tet-Mediated DNA Demethylation Is Required for SWI/SNF-Dependent Chromatin Remodeling and Histone-Modifying Activities That Trigger Expression of the Sp7 Osteoblast Master Gene during Mesenchymal Lineage Commitment.
Sepulveda H; Villagra A; Montecino M
Mol Cell Biol; 2017 Oct; 37(20):. PubMed ID: 28784721
[TBL] [Abstract][Full Text] [Related]
17. SWI/SNF chromatin-remodeling factors induce changes in DNA methylation to promote transcriptional activation.
Banine F; Bartlett C; Gunawardena R; Muchardt C; Yaniv M; Knudsen ES; Weissman BE; Sherman LS
Cancer Res; 2005 May; 65(9):3542-7. PubMed ID: 15867346
[TBL] [Abstract][Full Text] [Related]
18. The reversible epigenetic silencing of BRM: implications for clinical targeted therapy.
Glaros S; Cirrincione GM; Muchardt C; Kleer CG; Michael CW; Reisman D
Oncogene; 2007 Oct; 26(49):7058-66. PubMed ID: 17546055
[TBL] [Abstract][Full Text] [Related]
19. ARID1A loss in cancer: Towards a mechanistic understanding.
Mathur R
Pharmacol Ther; 2018 Oct; 190():15-23. PubMed ID: 29730444
[TBL] [Abstract][Full Text] [Related]
20. BRG1 HSA domain interactions with BCL7 proteins are critical for remodeling and gene expression.
Dietrich N; Trotter K; Ward JM; Archer TK
Life Sci Alliance; 2023 May; 6(5):. PubMed ID: 36801810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
